factually
Index/Topics/Neuralink's regulatory issues

Neuralink's regulatory issues

The FDA has allowed Neuralink to implant devices in humans without an inspection of its facilities, raising concerns about oversight and ethics.

Fact-Checks

1 result
Jan 14, 2026

What peer‑reviewed clinical trial evidence exists for Neuralink's implants in human patients?

There are no peer‑reviewed clinical trial publications of Neuralink’s implants in human patients in the reporting provided; available evidence about human use comes from company updates, press reports...